Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis2018-01-17T17:05:05-05:00
Bystander Modulation of Chemokine Receptor Expression on Peripheral Blood T Lymphocytes Mediated by Glatiramer Therapy Bystander Modulation of Chemokine Receptor Expression on Peripheral Blood T Lymphocytes Mediated by Glatiramer Therapy2018-01-17T17:04:58-05:00
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS2018-01-17T17:02:05-05:00
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis2018-01-17T16:59:38-05:00
